Search results
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 2 hours agoAZN boasts a Momentum Style Score of B and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating....
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 2 hours ago(See the last pharma stock roundup here:Pharma Stock Roundup: LLY’s CFO Departs, ABBV, AZN Drugs Get...
AstraZeneca PLC (OTCMKTS:AZNCF) Sees Large Drop in Short Interest
ETF DAILY NEWS· 1 day agoAstraZeneca PLC (OTCMKTS:AZNCF – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest totalling 21,000 ...
Why AstraZeneca plc (NASDAQ:AZN) is Investors’ One of Favorite International Dividend Stock?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since AstraZeneca...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks via Yahoo Finance· 1 day agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Yahoo Finance via AOL· 1 day agoAstraZeneca has set a target to become an $80 billion company, in sales, by 2030. In 2023, the...
Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks
Investor's Business Daily· 4 days agoNovo Nordisk stock also earns a spot on the IBD 50 list of top growth stocks, as well as IBD...
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 1 day agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 1 day agoThe company had two earlier flops in COPD treatment, but is now running a Phase 3 study of more than...
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 5 days agoAstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the company, ...